Search for: "Alcon Pharmaceuticals Ltd" Results 21 - 40 of 48
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
2 Jul 2020, 8:41 am by anne
Novartis Foreign Bribery Scheme Novartis AG, the Novartis parent company based in Switzerland, and former Novartis subsidiary Alcon Pte Ltd were alleged to have violated the Foreign Corrupt Practices Act by bribing officials in, respectively, Greece and Vietnam to induce the purchase of Novartis-branded pharmaceuticals and Alcon surgical products, and then falsifying their corporate books and records to conceal the bribes. [read post]
2 Dec 2009, 4:31 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://duncanbucknell.com/subscribe/   Highlights this week included: World AIDS Day: Make it happen (Patent Baristas) (IP Watch) Venezuela to examine all pharmaceutical patents (IP tango)   General World AIDS Day: Make it happen (Patent Baristas) (IP Watch) Biodiversity negotiations need to allow for flexibility in business, industry says (IP Watch) Brazilian government tailors a bill… [read post]
26 Apr 2007, 9:28 am
KG v Swingward Ltd (that's the short version of the case name, which covers a whole side of A4): this was a re-referred case from the UK on a variety of questions relating to trade mark infringement where a trader buys an original pharma manufacturer's trade mark-protected goods and repackages them, relabels or overstickers them or otherwise makes the appearance of the packaging look quite different. [read post]
8 Jul 2009, 7:04 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Kenya: Manufacturers, public heath interests clash over anti-counterfeit law; AIDS patients to bring Constitutional challenge (Intellectual Property Watch) (Afro-IP) (Intellectual Property Watch) Humira (Adalimumab) – US: Largest patent verdict in history – Abbott to pay $1.67 billion to Centocor because Humira found to… [read post]
16 Nov 2007, 4:00 am
: (LawFont),BrazilBrazil pays the price for compulsory licensing: (IAM), (Generic Pharmaceuticals & IP), CanadaThe Chronicle reports that Honourable Mr. [read post]